Docket Room.
HB 1962·MO·house

Modifies provisions relating to limits on selling or purchasing certain drugs

FailedFiled Dec 1, 2025
Sponsor: Tara Peters (R)
Latest Action

HCS Reported Do Pass (H)

Mar 26, 2026

Email me when HB 1962 moves

Committee action, floor votes, amendments and hearings. Free, no card, no password.

Already have an account? Track HB 1962. By continuing you agree to the Terms and Privacy Policy.

Summary

The bill limits how much ephedrine, phenylpropanolamine, and pseudoephedrine a person can buy or receive without a prescription, requires those products to be sold behind the pharmacy counter, and creates a fee‑based electronic tracking system for manufacturers. It applies to pharmacies, pharmacists, pharmacy technicians, retailers, and manufacturers, and it preempts stricter local rules.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Ask about HB 1962

3 free questions a day, no account

Vote

16 yes

0 no

HCS Reported Do Pass (H) - AYES: 16 NOES: 0 PRESENT: 0 · Mar 26, 2026

History

  1. HCS Voted Do Pass (H)
  2. HCS Reported Do Pass (H) - AYES: 16 NOES: 0 PRESENT: 0
  3. Executive Session Completed (H)
  4. Public Hearing Completed (H)
  5. Referred: Health and Mental Health(H)
  6. Read Second Time (H)
  7. Read First Time (H)
  8. Prefiled (H)

Sponsors

  • Tara Peters (R) · sponsor

Bill text

Read the official text ↗

Opens the legislature’s own copy.

Similar bills in other states

Loading the map of where bills like this one were filed.

Share

Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.

Track this bill

Get an email when HB 1962 moves: committee action, floor votes, amendments and hearings. Free, no card.

Track HB 1962 free

Or ask your AI assistant about HB 1962 directly:

Add to Claude, ChatGPT or Cursor
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice